| Shoprite Pharmacy Of East Haven | |
| 745 Foxon Rd, East Haven, Connecticut 06513 | |
| (475) 202-5184 |
| Name | Shoprite Pharmacy Of East Haven |
|---|---|
| Organization Name | East Haven Markets Llc |
| Location | 745 Foxon Rd, East Haven, Connecticut 06513 |
| Type | Pharmacy |
| Phone | (475) 202-5184 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced the first data from the dose-escalation portion of the ongoing Phase 1 study evaluating single agent AG-120, a first-in-class, oral, selective, potent inhibitor of mutant isocitrate dehydrogenase-1 (IDH1), in advanced solid tumors. The data are being presented today at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston. AG-120 is being developed in collaboration with Celgene.
Researchers at the Maxine Dunitz Neurosurgical Institute and Department of Neurosurgery at Cedars-Sinai will conduct a study to determine if several potentially toxic compounds that exist in polluted air are capable of entering the brain from the bloodstream and causing brain cancer.
"Eradicating global poverty starts with the health of the world's poor," Bill Frist, former U.S. Senate Majority leader and currently a member of the Millennium Challenge Corporation's (MCC) Board of Directors, writes in a Charlotte Observer opinion piece.
Vaccination studies from Mercer University (Ga.) headline the groundbreaking research being unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference.
› Verified 1 days ago
| NPI Number | 1245672237 |
| Organization Name | EAST HAVEN MARKETS LLC |
| Doing Business As | SHOPRITE PHARMACY OF EAST HAVEN |
| Type | Pharmacy |
| Address | 745 Foxon Rd, East Haven, CT 06513 |
| Phone Number | 475-202-5184 |
News Archive
Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced the first data from the dose-escalation portion of the ongoing Phase 1 study evaluating single agent AG-120, a first-in-class, oral, selective, potent inhibitor of mutant isocitrate dehydrogenase-1 (IDH1), in advanced solid tumors. The data are being presented today at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston. AG-120 is being developed in collaboration with Celgene.
Researchers at the Maxine Dunitz Neurosurgical Institute and Department of Neurosurgery at Cedars-Sinai will conduct a study to determine if several potentially toxic compounds that exist in polluted air are capable of entering the brain from the bloodstream and causing brain cancer.
"Eradicating global poverty starts with the health of the world's poor," Bill Frist, former U.S. Senate Majority leader and currently a member of the Millennium Challenge Corporation's (MCC) Board of Directors, writes in a Charlotte Observer opinion piece.
Vaccination studies from Mercer University (Ga.) headline the groundbreaking research being unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference.
› Verified 1 days ago
News Archive
Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced the first data from the dose-escalation portion of the ongoing Phase 1 study evaluating single agent AG-120, a first-in-class, oral, selective, potent inhibitor of mutant isocitrate dehydrogenase-1 (IDH1), in advanced solid tumors. The data are being presented today at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston. AG-120 is being developed in collaboration with Celgene.
Researchers at the Maxine Dunitz Neurosurgical Institute and Department of Neurosurgery at Cedars-Sinai will conduct a study to determine if several potentially toxic compounds that exist in polluted air are capable of entering the brain from the bloodstream and causing brain cancer.
"Eradicating global poverty starts with the health of the world's poor," Bill Frist, former U.S. Senate Majority leader and currently a member of the Millennium Challenge Corporation's (MCC) Board of Directors, writes in a Charlotte Observer opinion piece.
Vaccination studies from Mercer University (Ga.) headline the groundbreaking research being unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference.
› Verified 1 days ago
Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 875 Foxon Rd, East Haven, Connecticut 06513 Phone: (203) 467-2600 | |
Cvs Pharmacy #00857 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 660 Foxon Rd, East Haven, Connecticut 06513 Phone: (203) 467-8876 | |
Cvs Pharmacy #01968 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 369 Main St, East Haven, Connecticut 06512 Phone: (203) 468-6594 | |
Shoprite Pharmacy Of East Haven Type: Pharmacy Location: 745 Foxon Rd, East Haven, Connecticut 06513 Phone: (475) 202-5184 | |
Rite Aid Pharmacy #04092 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 645 Foxon Rd, East Haven, Connecticut 06513 Phone: (203) 468-1039 |